Healthcare provider profile · identity verified

Aaron Listopad

Family Practice · WEST MIDDLESEX, PA · NPI 1962476770

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1063	64
Levothyroxine Sodium	Levothyroxine Sodium	998	53
Potassium Chloride	Potassium Chloride	918	45
Amlodipine Besylate	Amlodipine Besylate	779	45
Famotidine	Famotidine	747	31
Furosemide	Furosemide	631	43
Metoprolol Tartrate	Metoprolol Tartrate	630	30
Lisinopril	Lisinopril	556	26
Eliquis	Apixaban	506	40
Losartan Potassium	Losartan Potassium	449	23
Donepezil Hcl	Donepezil Hcl	395	20
Pantoprazole Sodium	Pantoprazole Sodium	372	20
Omeprazole	Omeprazole	362	43
Tamsulosin Hcl	Tamsulosin Hcl	329	28
Citalopram Hbr	Citalopram Hydrobromide	315	12
Sertraline Hcl	Sertraline Hcl	315	18
Carvedilol	Carvedilol	293	17
Metoprolol Succinate	Metoprolol Succinate	286	20
Oxycodone Hcl	Oxycodone Hcl	266	20
Memantine Hcl	Memantine Hcl	257	12
Gabapentin	Gabapentin	250	16
Tramadol Hcl	Tramadol Hcl	248	17
Metformin Hcl	Metformin Hcl	208	suppressed
Allopurinol	Allopurinol	189	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	187	13
Simvastatin	Simvastatin	182	11
Clopidogrel	Clopidogrel Bisulfate	179	16
Lorazepam	Lorazepam	152	26
Duloxetine Hcl	Duloxetine Hcl	151	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	149	suppressed
Jardiance	Empagliflozin	139	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	136	suppressed
Methenamine Hippurate	Methenamine Hippurate	126	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	126	suppressed
Baclofen	Baclofen	123	suppressed
Myrbetriq	Mirabegron	122	suppressed
Prednisone	Prednisone	120	suppressed
Alendronate Sodium	Alendronate Sodium	113	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	113	15
Mirtazapine	Mirtazapine	112	suppressed
Xarelto	Rivaroxaban	110	suppressed
Pravastatin Sodium	Pravastatin Sodium	105	suppressed
Atenolol	Atenolol	98	suppressed
Trazodone Hcl	Trazodone Hcl	90	suppressed
Torsemide	Torsemide	89	suppressed
Nystatin	Nystatin	88	28
Escitalopram Oxalate	Escitalopram Oxalate	79	suppressed
Montelukast Sodium	Montelukast Sodium	76	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	76	suppressed
Hydralazine Hcl	Hydralazine Hcl	75	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	70	suppressed
Tradjenta	Linagliptin	64	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	63	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	62	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	59	suppressed
Finasteride	Finasteride	58	suppressed
Trospium Chloride	Trospium Chloride	58	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	56	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	55	21
Haloperidol	Haloperidol	54	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	54	suppressed
Latanoprost	Latanoprost	54	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	54	suppressed
Tizanidine Hcl	Tizanidine Hcl	54	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	54	suppressed
Fenofibrate	Fenofibrate	53	suppressed
Memantine Hcl Er	Memantine Hcl	53	suppressed
Valsartan	Valsartan	53	suppressed
Benztropine Mesylate	Benztropine Mesylate	52	suppressed
Gemtesa	Vibegron	52	suppressed
Trulicity	Dulaglutide	52	suppressed
Cephalexin	Cephalexin	51	16
Paroxetine Hcl	Paroxetine Hcl	51	suppressed
Humalog Kwikpen U-100	Insulin Lispro	48	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	43	19
Doxazosin Mesylate	Doxazosin Mesylate	41	suppressed
Potassium Citrate Er	Potassium Citrate	41	suppressed
Ropinirole Hcl	Ropinirole Hcl	41	suppressed
Alprazolam	Alprazolam	40	suppressed
Amantadine	Amantadine Hcl	40	suppressed
Entacapone	Entacapone	40	suppressed
Primidone	Primidone	38	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	36	suppressed
Fenofibrate	Fenofibrate,micronized	36	suppressed
Ondansetron Odt	Ondansetron	36	24
Diltiazem 24hr Er	Diltiazem Hcl	35	suppressed
Nystop	Nystatin	35	16
Spironolactone	Spironolactone	35	suppressed
Bumetanide	Bumetanide	34	suppressed
Buspirone Hcl	Buspirone Hcl	34	suppressed
Clotrimazole	Clotrimazole	33	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	32	suppressed
Fluticasone Propionate	Fluticasone Propionate	29	suppressed
Levetiracetam	Levetiracetam	28	suppressed
Incruse Ellipta	Umeclidinium Bromide	27	suppressed
Novolin N Flexpen	Insulin Nph Human Isophane	27	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	26	suppressed
Clobetasol Propionate	Clobetasol Propionate	26	suppressed
Glipizide	Glipizide	26	suppressed
Glipizide Er	Glipizide	26	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	suppressed
Jantoven	Warfarin Sodium	25	suppressed
Budesonide	Budesonide	22	suppressed
Fentanyl	Fentanyl	22	suppressed
Glimepiride	Glimepiride	22	suppressed
Naproxen	Naproxen	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	20	suppressed
Enalapril Maleate	Enalapril Maleate	19	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	19	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	18	suppressed
Metformin Hcl Er	Metformin Hcl	18	suppressed
Sodium Chloride	0.9 % Sodium Chloride	18	suppressed
Amoxicillin	Amoxicillin	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Methotrexate	Methotrexate Sodium	17	suppressed
Budesonide Dr	Budesonide	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Mirabegron Er	Mirabegron	15	suppressed
Rivastigmine	Rivastigmine	15	suppressed
Methylprednisolone	Methylprednisolone	14	12
Timolol Maleate	Timolol Maleate	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Pregabalin	Pregabalin	13	suppressed
Santyl	Collagenase Clostridium Hist.	13	suppressed
Topiramate	Topiramate	13	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Forteo	Teriparatide	11	suppressed
Lidocaine Hcl	Lidocaine Hcl	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	11	suppressed
Sodium Chloride	Sodium Chloride 0.45 %	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error